Today is World Malaria Day. Malaria is usually framed as a public health issue, but it is just as much a capital allocation problem. The treatments and preventative medicines have existed for decades, so this is not a scientific gap. It is an economic one. Most anti-malarial medicines sit in a part of the market with limited pricing power, demand concentrated in lower income regions, and procurement often controlled by governments or global health programs. The return profile

Pro Pharmaceuticals Group returns to WHX Dubai 2026 to meet existing global suppliers and customers and engage GCC organisations in clinical trial procurement and complex medicine access.

Sandip Manku, Managing Director and Pharmacist at Pro Pharmaceuticals Group, attended Medicines Management 2025 (MM2025) on Friday 28 November. It was an excellent opportunity to meet with our hospital customers, reconnect with colleagues across the pharmacy sector, and discuss the real-world pressures that medicine shortages continue to place on clinicians and patients nationwide. One session that strongly aligned with our work highlighted several key themes: Most hospitals

Pro Pharmaceuticals Group has launched a new initiative to support hospitals with early visibility on emerging medicine supply pressures. This service strengthens planning, improves continuity, and helps clinical teams stay ahead of potential disruptions.

To our valued clients, suppliers, and partners celebrating across India and around the world — may the Festival of Lights bring happiness, health, and prosperity to you and your families. Warm wishes from all of us at Pro Pharmaceuticals Group.

Pro Pharmaceuticals Group will attend CPhI Worldwide 2025 in Frankfurt for the ninth year, focusing on Australian product registrations, comparator (RLD) supplies, and building global partnerships.

Pro Pharmaceuticals Group will attend Expopharm 2025 in Düsseldorf from 16–18 September. Directors Sandip Manku and Lukasz Nowaczek will be meeting long-term partners and exploring new global supplier and customer opportunities at Europe’s leading pharmacy trade fair.

Pro Pharmaceuticals Group continues to strengthen its position as a trusted partner in global pharmaceutical supply, with a growing portfolio of structured export agreements supporting clinical research and healthcare delivery in Europe and beyond. Our ability to source registered pharmaceutical products from major global markets — including Europe and the United States — enables us to meet complex clinical and regulatory requirements for comparator and specialty medicines. L

Celebrating 10 Years of ProPG

Pro Pharmaceuticals Group Now Registered Supplier with the United Nations Global Marketplace